Biomerieux SA - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Biomerieux SA Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Biomerieux SA. The Group's principal activity is to provide clinical diagnosis. The Group offers 'in vitro' diagnosis which serves as the basis for medical diagnosis, patient treatment and therapy monitoring. The Group contributes to the field of infectious diseases such as hepatitis, HIV, tuberculosis and respiratory infection and pathologies such as cancer and cardiovascular diseases. The Group performs clinical diagnosis through three technologies, bacteriology, immunoassays and molecular biology. The Group operates in Europe, North America, Asia-Pacific and Latin America. In 2007, the Group acquired BTF.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report